NO923839D0 - Kombinasjoner av hepatitt c-virus(hcv)-antigener for anvendelse i immunoanalyser for anti-hcv-antistoffer - Google Patents

Kombinasjoner av hepatitt c-virus(hcv)-antigener for anvendelse i immunoanalyser for anti-hcv-antistoffer

Info

Publication number
NO923839D0
NO923839D0 NO923839A NO923839A NO923839D0 NO 923839 D0 NO923839 D0 NO 923839D0 NO 923839 A NO923839 A NO 923839A NO 923839 A NO923839 A NO 923839A NO 923839 D0 NO923839 D0 NO 923839D0
Authority
NO
Norway
Prior art keywords
hcv
domain
combinations
antigens
antigen
Prior art date
Application number
NO923839A
Other languages
English (en)
Other versions
NO923839L (no
NO310241B1 (no
Inventor
Michael Houghton
Qui-Lim Choo
George Kuo
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24005897&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO923839(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of NO923839D0 publication Critical patent/NO923839D0/no
Publication of NO923839L publication Critical patent/NO923839L/no
Publication of NO310241B1 publication Critical patent/NO310241B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pinball Game Machines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Thermistors And Varistors (AREA)
NO19923839A 1990-04-04 1992-10-01 Kombinasjoner av hepatitt C-virus-(HCV)-antigener og fremgangsmåte for detektering av antistoffer og sett for utförelseav en analyse NO310241B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50435290A 1990-04-04 1990-04-04
PCT/US1991/002225 WO1991015771A1 (en) 1990-04-04 1991-03-29 Combinations of hepatitis c virus (hcv) antigens for use in immunoassays for anti-hcv antibodies

Publications (3)

Publication Number Publication Date
NO923839D0 true NO923839D0 (no) 1992-10-01
NO923839L NO923839L (no) 1992-11-19
NO310241B1 NO310241B1 (no) 2001-06-11

Family

ID=24005897

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19923839A NO310241B1 (no) 1990-04-04 1992-10-01 Kombinasjoner av hepatitt C-virus-(HCV)-antigener og fremgangsmåte for detektering av antistoffer og sett for utförelseav en analyse

Country Status (25)

Country Link
EP (2) EP0450931B1 (no)
JP (1) JP2733138B2 (no)
KR (1) KR100206150B1 (no)
AT (2) ATE139343T1 (no)
BG (1) BG61291B1 (no)
BR (1) BR9106309A (no)
CY (1) CY1881A (no)
DE (2) DE69120138T2 (no)
DK (2) DK0450931T3 (no)
ES (2) ES2134388T5 (no)
FI (1) FI106317B (no)
GB (1) GB2257784B (no)
GR (2) GR3020964T3 (no)
HU (1) HU217025B (no)
IE (1) IE911105A1 (no)
IL (2) IL97741A0 (no)
LT (1) LT3808B (no)
LV (2) LV10344A (no)
MY (1) MY107499A (no)
NO (1) NO310241B1 (no)
PL (1) PL172133B1 (no)
RO (1) RO109916B1 (no)
RU (1) RU2130969C1 (no)
UA (1) UA41266C2 (no)
WO (1) WO1991015771A1 (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9006422A (pt) 1989-12-18 1991-09-24 Wellcome Found Processo para preparar um polipeptidio viral pt-nanbh e processo para detectar o mesmo
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
EP1018558A3 (en) * 1990-04-06 2002-06-05 Genelabs Technologies, Inc. Hepatitis C Virus Epitopes
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
SK285624B6 (sk) * 1990-11-08 2007-05-03 Chiron Corporation Hepatitis C vírusový (HCV) skrátený asialoglykoproteín, kompozícia s jeho obsahom a jeho použitie
US6274148B1 (en) 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
DK0489968T3 (da) * 1990-12-14 1997-03-24 Innogenetics Nv Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
US6007982A (en) * 1990-12-14 1999-12-28 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
US5910404A (en) * 1990-12-14 1999-06-08 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
DE4041304A1 (de) * 1990-12-21 1992-06-25 Mikrogen Molekularbiol Entw Von strukturproteinen des hepatitis c-virus abgeleitete polypeptide, testkits, die diese polypeptide enthalten und impfstoffe gegen infektionen von hepatitis c-viren
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
EP0573624A4 (en) * 1991-11-07 1997-09-17 Baxter Diagnostics Inc Epitope mapping ot the c33c region of hcv
DE610436T1 (de) * 1991-11-21 1995-08-03 Common Services Agency Detektion des Hepatis-C Virus.
WO1993015207A2 (en) * 1992-02-04 1993-08-05 Viagene, Inc. Hepatitis therapeutics
GB9203803D0 (en) * 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
US6153378A (en) * 1992-10-16 2000-11-28 Bionova Corporation Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
JP2778886B2 (ja) * 1992-10-16 1998-07-23 エバーニュー バイオテック インコーポレイティド Ｃ型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット
EP0593291A3 (en) * 1992-10-16 1995-03-15 Evernew Biotech Inc Non-structural protein of the hepatitis C virus, as well as diagnostic procedure and test kit.
WO1994013164A1 (en) 1992-12-10 1994-06-23 Nike International Ltd. Bonding of rubber to plastic in footwear
WO1994027153A1 (en) * 1993-05-10 1994-11-24 Chiron Corporation Methods of typing hepatitis c virus and reagents for use therein
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
JPH0862219A (ja) * 1994-08-19 1996-03-08 Dainabotsuto Kk 還元型抗原に対する抗体アッセイ試薬及びそれを使用した測定方法
JP3665371B2 (ja) * 1994-08-31 2005-06-29 株式会社先端生命科学研究所 Ｃ型肝炎ウイルス感染又はグループ判定のためのエピトープキメラ抗原ペプチド、その製法、及びそれを使用する感染又はグループ判定法
CA2172305A1 (en) * 1995-03-30 1996-10-01 Muneo Aoyama Multiple antigenic peptide comprising at least two hepatitis c virus-associated peptides
IL118364A0 (en) * 1995-05-22 1996-09-12 Bionova Corp A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus
FR2734639B1 (fr) * 1995-05-26 1997-10-03 Parteurop Methode de pronostic de l'evolution d'une infection par le virus de l'hepatite c, et necessaire pour sa mise en oeuvre
FR2737209B1 (fr) 1995-07-25 1997-09-19 Bio Merieux Peptide capable d'etre reconnu par des anticorps reconnaissant l'antigene c33 du virus de l'hepatite c
US6127116A (en) 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
JP3715027B2 (ja) 1996-05-07 2005-11-09 シスメックス株式会社 Ｃ型肝炎ウイルス感染症診断薬
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
CA2303123C (en) * 1997-09-22 2006-04-11 Chiron Corporation Method for detecting antibodies in a sample
AU6098900A (en) * 1999-07-15 2001-02-05 Bayer Corporation The use of specific antibody titers to predict hepatic failure in people infected with hepatitis c virus
US6562346B1 (en) 1999-10-27 2003-05-13 Chiron Corporation Activation of HCV-specific T cells
US6986892B1 (en) * 1999-11-24 2006-01-17 Chiron Corporation Immunogenic Hepatitis C virus non-structural polypeptides
ATE376558T1 (de) * 1999-11-24 2007-11-15 Novartis Vaccines & Diagnostic Neues nichtstrukturelles hcv polypeptid
US6632601B2 (en) 2000-06-15 2003-10-14 Chiron Corporation Immunoassays for anti-HCV antibodies
US7491808B2 (en) 2000-06-15 2009-02-17 Novartis Vaccines And Diagnostics, Inc. HCV non-structural protein mutants and uses thereof
RU2286172C2 (ru) 2000-08-17 2006-10-27 Трипеп Аб Вакцины, содержащие рибавирин, и способы их использования
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
WO2002014362A2 (en) 2000-08-17 2002-02-21 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
FR2839722A1 (fr) * 2002-05-17 2003-11-21 Bio Merieux Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
CA2498228C (en) 2002-09-09 2011-03-22 Chiron Corporation Hcv assay
NZ551646A (en) 2004-06-09 2010-11-26 Pathogen Removal & Diagnostic Technologies Inc Particles embedded in a porous substrate for removing target analyte from a sample
JP4005093B2 (ja) * 2005-05-25 2007-11-07 シスメックス株式会社 Ｃ型肝炎ウイルス感染症診断薬および抗ｈｃｖ抗体検出方法
JP2005274584A (ja) * 2005-05-25 2005-10-06 Sysmex Corp Ｃ型肝炎ウイルス感染症診断薬の製造方法
WO2007031867A2 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-stru tural ns3/4a fusion gene
KR20080113358A (ko) 2006-03-09 2008-12-30 트랜스진 에스.에이. Ｃ형 간염 바이러스 비구조 융합 단백질
US20080227111A1 (en) 2007-03-16 2008-09-18 Sysmex Corporation Reagent kit and method for measuring hcv antibody
EP2185195A2 (en) 2007-08-16 2010-05-19 Tripep Ab Immunogen platform
WO2009130588A2 (en) 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
US10088483B2 (en) 2014-10-29 2018-10-02 Abbott Laboratories Subject anti-HCV antibody detection assays employing NS3 capture peptides
JP2018124277A (ja) * 2017-02-02 2018-08-09 三洋化成工業株式会社 粒子含有組成物、免疫測定用試薬、免疫測定方法及び粒子の保存方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US456637A (en) 1891-07-28 Fence
US390599A (en) 1888-10-02 Tool for weaver s use
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4870008A (en) * 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
CA1341423C (en) † 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
US4751180A (en) * 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
CN1049686C (zh) * 1987-11-18 2000-02-23 希龙股份有限公司 非ａ和非ｂ肝炎病毒的诊断及疫苗
JP2656995B2 (ja) † 1989-03-17 1997-09-24 カイロン コーポレイション Ｎａｎｂｖの診断用薬
BR9006422A (pt) * 1989-12-18 1991-09-24 Wellcome Found Processo para preparar um polipeptidio viral pt-nanbh e processo para detectar o mesmo
CA2032907C (en) † 1989-12-22 2002-05-14 Richard R. Lesniewski Hepatitis c assay

Also Published As

Publication number Publication date
DE69120138D1 (de) 1996-07-18
GB2257784B (en) 1995-01-04
HU9203146D0 (en) 1992-12-28
BG96943A (bg) 1993-12-24
IL97741A0 (en) 1992-06-21
LV10344B (en) 1996-02-20
ATE182684T1 (de) 1999-08-15
MY107499A (en) 1995-12-30
AU7651091A (en) 1991-10-30
ATE139343T1 (de) 1996-06-15
CY1881A (en) 1996-04-05
HUT62706A (en) 1993-05-28
LT3808B (en) 1996-03-25
EP0693687B2 (en) 2008-06-04
BG61291B1 (en) 1997-04-30
IL170719A (en) 2011-04-28
FI106317B (fi) 2001-01-15
DE69120138T2 (de) 1996-11-14
ES2088465T3 (es) 1996-08-16
JP2733138B2 (ja) 1998-03-30
DK0693687T4 (da) 2008-09-22
HU217025B (hu) 1999-11-29
AU639560B2 (en) 1993-07-29
DK0450931T3 (da) 1996-07-01
NO923839L (no) 1992-11-19
ES2134388T3 (es) 1999-10-01
GB2257784A (en) 1993-01-20
DE69131488T2 (de) 1999-11-18
EP0450931B1 (en) 1996-06-12
ES2134388T5 (es) 2008-12-01
RU2130969C1 (ru) 1999-05-27
DK0693687T3 (da) 1999-11-29
KR100206150B1 (ko) 1999-07-01
LV10344A (en) 1994-10-20
LTIP1747A (en) 1995-07-25
EP0693687A1 (en) 1996-01-24
NO310241B1 (no) 2001-06-11
IE911105A1 (en) 1991-10-09
GR3031361T3 (en) 2000-01-31
BR9106309A (pt) 1993-04-20
UA41266C2 (uk) 2001-09-17
GR3020964T3 (en) 1996-12-31
FI924349A0 (fi) 1992-09-28
EP0693687B1 (en) 1999-07-28
EP0450931A1 (en) 1991-10-09
FI924349A (fi) 1992-09-28
JPH05508219A (ja) 1993-11-18
RO109916B1 (ro) 1995-07-28
GB9220480D0 (en) 1992-11-25
DE69131488D1 (de) 1999-09-02
WO1991015771A1 (en) 1991-10-17
PL172133B1 (pl) 1997-08-29

Similar Documents

Publication Publication Date Title
NO923839D0 (no) Kombinasjoner av hepatitt c-virus(hcv)-antigener for anvendelse i immunoanalyser for anti-hcv-antistoffer
NO934542D0 (no) Hepatitt C virus (HCV) polypeptider
BRPI0111682B8 (pt) suporte sólido de imunoensaio, kit de teste de imunodiagnóstico, métodos de produção de um suporte sólido de imunoensaio, e de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e, uso de um suporte sólido de imunoensaio
ES2171414T3 (es) Inmunoensayos para anticuerpos anti-hcv utilizando antigenos con epitopos conformacionales.
FI942369A (fi) Hepatitis-C-virustesti
ATE410693T1 (de) Hcv-test
PT97247A (pt) Processo de preparacao de combinacoes de antigenios do virus da hepapite c (hcv) para uso em imunoensaios para anticorpos anti-hcv
DK0599913T3 (da) Monoklonale antistoffer mod formodet hepatitis C-virus NS5-proteiner og anvendelsesmetoder af samme
TH11517EX (th) การใช้แอนติเจนชนิดต่างๆของไวรัสตับอักเสบซี (hcv) ร่วมกัน เพื่อใช้ในการวิเคราะห์ทางอิมมูนสำหรับแอนติ - hcv แอนติบอดี

Legal Events

Date Code Title Description
MK1K Patent expired